Scholars Central

Conference abstractPublished 20 Nov 2013

Alternative sources of mesenchymal stem cells for islet generation for diabetes research and therapeutics

Authors: Ramesh Bhonde

Manipal Institute of Regenerative Medicine, India

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Bone marrow-derived mesenchymal stem cells (BMSCs) have been used for allogeneic application in tissue engineering but have certain drawbacks. Therefore, mesenchymal stromal cells (MSCs) derived from other postnatal tissue sources have been considered as an alternative. The human umbilical cord, amnion and placenta are easily available non-controversial tissue sources of human origin and their collection is non-invasive. These sources of MSCs are not subjected to ethical constraints, as in the case of embryonic stem cells. MSCs are multipotent stem cells and have the ability to differentiate into various cell types of the mesodermal lineage. The aim of this study was to establish a reproducible method for the isolation of MSCs from human umbilical cord, amnion, and placenta to compare their propensity towards pancreatic/islet lineage for utilization as a cell therapy product. Experimental Design & Methods: Mesenchymal stromal cells (MSCs) were isolated from umbilical cord (UC MSC) amnion (AMSC) and, placenta (PMSCS) adipose tissue (AT) and dental pulp (DP) using different culture conditions with respect choice of medium and serum to optimize medium-scale production. On further expansion upto five passages, they were analyzed for surface as well as cytoskeletal markers. Their multilineage differentiation potential was tested by subjecting these to lineage specific differentiation cocktails. Results: Extensive phenotypic characterization analysis of these cells, using flow cytometry and antibody staining methods, have shown that the MSCs expressed CD13, CD44, CD73, CD90, and CDIO5, but not CD31, CD34, CD45 and HLA-DR. These MSCs were also found to express vimentin, desmin and alpha-smooth muscle actin as cytoskeletal mesenchymal cell markers. When these MSCs were subjected to specific differentiation cocktails they could differentiate into adipogenic, chondrogenic, oesteogenic and islet lineage. Conclusions: Mesenchymal stromal cells can be expanded from different sources of human origin retaining their multilineage differentiation potential in vitro. They represent a relatively homogeneous population of mesenchymal stromal cells. Our results indicate that fetal as well as postnatal tissues represent a rich source of mesenchymal stromal cells suitable for islet neogenesis in vitro. Therefore adipose tissue and dental pulp MSCs could be regarded as an alternative source of MSCs for experimental and clinical needs. Further studies are planned to examine their safety and efficacy in animal models of type1 and type 2 diabetes.

Subjects

Biology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Cell Science & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Cell Science & Therapy
  • SubjectBiology
  • BylineArticles whose byline prints “Ramesh Bhonde”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels